Savencia SA (SAVE)
Euronext Paris · France · prices in EUR · close of 27 Oct 2026
Key indicators
| Last close | EUR 56.00 |
|---|---|
| 52-week range | 54.20 – 74.40 |
| Return, 1 month / 3 months | +0.4% / −11.9% |
| Return, 1 year / 3 years | −7.9% / +7.8% |
| Trend | Below its 200-day average |
| RSI (14) | 45 |
| Volatility (1 year) | 28.2% |
| Worst drawdown (1 year) | -26.7% |
| Average daily value traded | 0.06M EUR |
| Dividend yield | 2.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Savencia is a French food group based in France that makes and markets dairy products, with cheese as its core business. Its cheese brands are sold in supermarkets and to food-service customers in France and abroad. The group also produces other food items, including chocolate products and seafood, through its subsidiaries, and it supplies both retail and professional buyers across many countries.
Savencia SA trades under the code SAVE on the Euronext Paris in France, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Savencia SA (SAVE) trades on the Euronext Paris in France. It last closed at EUR 56.00 on 27 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 296 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 7.9% and over the last three months it fell 11.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 50 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -9.5% | ||
| From 52-week high | -24.5% | ||
| Momentum | 43 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -12.0% | ||
| 6-month return | -14.8% | ||
| 12-month return, skipping the last month | -8.3% | ||
| Stability (higher is calmer) | 70 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 28.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.7% | ||
| Liquidity | 58 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.06M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 42 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.5% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.0% |
|---|---|
| 1 month | +0.4% |
| 3 months | −11.9% |
| 6 months | −14.8% |
| 1 year | −7.9% |
| 3 years | +7.8% |
| 5 years | −1.1% |
Signals
| 50-day / 200-day average | 58.74 / 61.87 |
|---|---|
| Golden / death cross (60 days) | Death, 21 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.12 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 May 2026 | EUR 1.4000 |
| 12 May 2025 | EUR 1.6000 |
| 13 May 2024 | EUR 1.4000 |
| 15 May 2023 | EUR 1.3000 |
| 16 May 2022 | EUR 1.5000 |
| 17 May 2021 | EUR 1.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.